Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: A unifying hypothesis regarding etiology and pathogenesis

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 6, 2012, Pages 591-600

  Leslie, Kevin O ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; DISEASE COURSE; FIBROSING ALVEOLITIS; HUMAN; LUNG; LUNG INJURY; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE;

DISEASE PROGRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG INJURY; MODELS, BIOLOGICAL; RECURRENCE;

EID: 84860573175     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0511-OA     Document Type: Article

References (64)

1. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001;17(2):163-167. (Pubitemid 32600572)
2. Raghu G, Collard HR, Egan JJ, et al; for ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824.
3. Klingsberg RC, Mutsaers SE, Lasky JA. Current clinical trials for the treatment of idiopathic pulmonary fibrosis. Respirology. 2010;15(1):19-31.
4. Nannini C, Ryu JH, Matteson EL. Lung disease in rheumatoid arthritis. Curr Opin Rheumatol. 2008;20(3):340-346. (Pubitemid 351483326)
5. Crystal RG, Bitterman PB, Mossman B, et al. Future research directions in idiopathic pulmonary fibrosis: Summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2002;166(2):236-246. (Pubitemid 34765460)
6. Lasky JA, Ortiz LA. Antifibrotic therapy for the treatment of pulmonary fibrosis. Am J Med Sci. 2001;322(4):213-221. (Pubitemid 32973274)
7. Chilosi M, Doglioni C, Murer B, Poletti V. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(1):7-18.
8. Ding Q, Luckhardt T, Hecker L, et al. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs. 2011;71(8):981-1001.
9. Sisson TH, Mendez M, Choi K, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med. 2009;181(3):254-263.
10. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. ProcAm Thorac Soc. 2006;3(4):364-372. (Pubitemid 43845414)
11. Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006;3(4):350-356. (Pubitemid 43845412)
12. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;178(7):729-737.
13. Heppleston A. The pathology of honeycomb lung. Thorax. 1956; 1177-1193.
14. Pimentel J. Tridimensional photographic reconstruction in a study of the pathogenesis of honeycomb lung. Thorax. 1967;22(5):444-452.
15. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(7):810-816. (Pubitemid 44511663)
16. Fernandez Perez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest. 2009;137(1):129-137.
17. Steele MP, Brown KK. Genetic predisposition to respiratory diseases: Infiltrative lung diseases. Respiration. 2007;74(6):601-608. (Pubitemid 350164503)
18. Stemmermann GN. Chronic familial lung disease. Am Rev Respir Dis. 1967;95(4):663-669.
19. Swaye P, Van Ordstrand HS, McCormack LJ, Wolpaw SE. Familial Hamman-Rich syndrome: Report of eight cases. Dis Chest. 1969;55(1):7-12.
20. Solliday N, Williams J, Gaensler E, Coutu RE, Carrington CB. Familial chronic interstitial pneumonia. Am Rev Respir Dis. 1973;108(2);193-204.
21. Murphy A, O'Sullivan BJ. Familial fibrosing alveolitis. IrJ Med Sci. 1981; 150(7):204-209. (Pubitemid 11021425)
22. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000;55(2):143-146. (Pubitemid 30245956)
23. Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr. 2001;139(1):85-92. (Pubitemid 32613992)
24. Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med. 2006;100(10):1734-1741. (Pubitemid 44283761)
25. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis: Analysis of clinical and pathologic findings in three cases. Chest. 1993;103(6):1808-1812. (Pubitemid 23174318)
26. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176(7):636-643. (Pubitemid 47503070)
27. Collard HR, Calfee CS, Wolters PJ, et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010;299(1):L3-L7.
28. Kondoh Y, Taniguchi H, Katsuta T, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2010;27(2): 103-110.
29. Simon-Blancal V, Freynet O, Nunes H, et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors [published online ahead of print August 12, 2011]. Respiration. doi:10.1159/000329891.
30. Wootton SC, Kim DS, Kondoh Y, et al. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183(12):1698-1702.
31. Tcherakian C, Cottin V, Brillet PY, et al. Progression of idiopathic pulmonary fibrosis: Lessons from asymmetrical disease. Thorax. 66(3):226-231.
32. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003;124(4):1215-1223. (Pubitemid 37290029)
33. Liebow A, Carrington C. The interstitial pneumonias. In: Simon M, Potchen E, LeMay M, eds. Frontiers of Pulmonary Radiology Pathophysiologic, Roentgenographic and Radioisotopic Considerations. Orlando, FL: Grune & Stratton; 1969:109-142.
34. Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999;116(5):1168-1174. (Pubitemid 29535965)
35. Travis W, King T, Bateman E, et al; for American Thoracic Society/ European International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. ATS/ERS joint statement adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 [erratum in Am J Respir Crit Care Med. 2002;166(3:426)]. Am J Respir Crit Care Med. 2002;165(2):277-304.
36. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: Histologic study of biopsy and explant specimens. Am J Surg Pathol. 2002;26(12):1567-1577. (Pubitemid 35387220)
37. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest. 2009;136(1):23-30.
38. Churg A, Sin DD, Everett D, Brown K, Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009;33(12):1765-1770.
39. Cool CD, Groshong SD, Rai PR, Henson PM, Stewart JS, Brown KK. Fibroblast foci are not discrete sites of lung injury or repair: The fibroblast reticulum. Am J Respir Crit Care Med. 2006;174(6):654-658. (Pubitemid 44395332)
40. Suki B, Bates JH. Lung tissue mechanics as an emergent phenomenon. J Appl Physiol. 2011;110(4):1111-1118.
41. Tschumperlin DJ, Boudreault F, Liu F. Recent advances and new opportunities in lung mechanobiology. J Biomech. 2009;43(1):99-107.
42. Myers JL, Katzenstein AL. Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia. Chest. 1988;94(6):1309-1311. (Pubitemid 19002811)
43. Galvin JR, Frazier AA, Franks TJ. Collaborative radiologic and histopathologic assessment of fibrotic lung disease. Radiology. 2010;255(3):692-706.
44. Colombat M, Mal H, Groussard O, et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. Hum Pathol. 2007;38(1):60-65. (Pubitemid 44883363)
45. Pitsiou G, Papakosta D, Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration. 2011;82(3):294-304.
46. Honda Y, Tsunematsu K, Suzuki A, Akino T. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung. 1988;166(5):293-301.
47. Robinson PC, Watters LC, King TE, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis. 1988;137(3):585-591.
48. McCormack FX, King TE Jr., Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis: abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis. 1991;144(1):160-166.
49. Kuroki Y, Tsutahara S, Shijubo N, et al. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis. 1993;147(3):723-729. (Pubitemid 23072668)
50. Lenz AG, Meyer B, Costabel U, Maier K. Bronchoalveolar lavage fluid proteins in human lung disease: Analysis by two-dimensional electrophoresis. Electrophoresis. 1993;14(3):242-244. (Pubitemid 23116197)
51. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995;152 (6, pt 1):1860-1866.
52. Honda Y, Kuroki Y, Shijubo N, et al. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration. 1995;62(2):64-69.
53. McCormack FX, King TE, Jr., Bucher BL, Nielsen L, Mason RJ, McCormac FX. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995;152(2):751-759.
54. McFadden RG. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis [comment on Am J Respir Crit Care Med. 1995;152(2):751-759]. Am J Respir Crit Care Med. 1996;154(3, pt 1):825-856.
55. Gunther A, Schmidt R, Nix F, et al. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J. 1999;14(3):565-573. (Pubitemid 29479720)
56. Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162(3, pt 1):1109-1114.
57. Rugonyi S, Biswas SC, Hall SB. The biophysical function of pulmonary surfactant. Respir Physiol Neurobiol. 2008;163(1):244-255.
58. Avery M, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-523.
59. Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010;61;105-119.
60. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009;12(4):253-274.
61. Cosgrove GP, Brown KK, Schiemann WP, et al. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: A role in aberrant angiogenesis. Am J Respir Crit Care Med. 2004;170(3):242-251. (Pubitemid 38971408)
62. Tobin RW, Pope CE II, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158(6):1804-1808. (Pubitemid 29008818)
63. Lee JS, Ryu JH, Elicker BM, etal. Gastroesophageal reflux therapy is associated with longer survival in idiopathic pulmonary fibrosis [published online ahead of print June 23, 2011]. Am J Respir Crit Care Med. doi:10.1164/rccm.201101-0138OC.
64. Sakamoto K, Taniguchi H, Kondoh Y, Ono K, Hasegawa Y, Kitaichi M. Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease. Eur Respir Rev. 2009;18(112):129-132.